ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2021

Empagliflozin Improves Liver Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

Haleh Chehrehgosha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.